CV vs OXY
CapsoVision, Inc. Common Stock (CV) versus OXY (OXY) — a side-by-side from cached financials, not a winner call.
CapsoVision, Inc. Common Stock (CV) is a medical devices company listed on US.
OXY (OXY) common stock.
Latest reported CV revenue for 2025-09-30 was $3.5M. Net income was -$7.9M. Revenue was up 6.7% from 2025-06-30 to 2025-09-30. CV currently screens at market cap $359.2M.
OXY does not have a complete income-statement cache yet.
CV currently screens at market cap $359.2M. OXY currently screens at market cap $0.
Not investment advice. Open the CV and OXY stock pages for the full models.
Not investment advice.